News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-17 6:17:47 pm Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns SeekingAlpha
2024-03-13 11:15:0 pm Japan’s Stock Market Is Back, and It Isn’t Too Late to Buy Barrons.com
2024-03-13 5:0:0 am Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia Business Wire
2024-03-11 9:0:10 am Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock? Zacks
2024-03-11 8:40:9 am TAK or STVN: Which Is the Better Value Stock Right Now? Zacks
2024-03-11 6:40:16 am Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? Zacks
2024-03-05 8:55:0 am Alexandria (ARE) Announces Lease Extension at Kendall Square Zacks
2024-02-26 8:30:0 pm Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E. PR Newswire
2024-02-26 8:30:0 pm Takeda and Biological E. Limited Collaborate to Accelerate Access to Dengue Vaccine in Endemic Areas Business Wire
   

Please consider a small donation if you think this website provides you with relevant information